share_log

Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Beraud Jill

SEC ·  May 3 20:46
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more